IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,000 | -92.5% | 200 | -91.5% | 0.00% | -100.0% |
| Q1 2021 | $106,000 | +863.6% | 2,350 | +1075.0% | 0.00% | – |
| Q4 2020 | $11,000 | -35.3% | 200 | -44.4% | 0.00% | – |
| Q1 2020 | $17,000 | -48.5% | 360 | -33.8% | 0.00% | – |
| Q4 2019 | $33,000 | 0.0% | 544 | -1.1% | 0.00% | – |
| Q3 2019 | $33,000 | +37.5% | 550 | +48.2% | 0.00% | – |
| Q2 2019 | $24,000 | -4.0% | 371 | +21.6% | 0.00% | – |
| Q1 2019 | $25,000 | +150.0% | 305 | +67.6% | 0.00% | – |
| Q4 2018 | $10,000 | +11.1% | 182 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 182 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | 0.0% | 182 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | -42.9% | 182 | -34.3% | 0.00% | – |
| Q4 2017 | $14,000 | +55.6% | 277 | +52.2% | 0.00% | – |
| Q3 2017 | $9,000 | 0.0% | 182 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
| Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
| BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
| Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
| Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
| Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
| Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
| SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
| HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
| BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |